BG
ELOS

BlackRock Group’s Syneron Medical Ltd ELOS Stock Holding History

BlackRock Group’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-16,547
Closed -$118K – 3071
2015
Q3 		$118K Hold
16,547
– – ﹤0.01% 2667
2015
Q2 		$176K Hold
16,547
– – ﹤0.01% 2618
2015
Q1 		$205K Hold
16,547
– – ﹤0.01% 2490
2014
Q4 		$154K Hold
16,547
– – ﹤0.01% 2582
2014
Q3 		$166K Hold
16,547
– – ﹤0.01% 2496
2014
Q2 		$171K Buy
+16,547
New +$179K ﹤0.01% 2493

Other funds holding ELOS

SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock Group's ELOS Position: Q4 2015 in Review

BlackRock Group sold out of Syneron Medical Ltd (ELOS) in Q4 2015, closing a stake of 16,547 shares — an estimated $118K sold.

BlackRock Group first reported a position in ELOS in Q2 2014 and held it in 6 quarters. The position peaked at $205K in Q1 2015. 57 funds tracked by Wall St. Rank hold ELOS as of Q4 2015.

  • BlackRock Group reported no remaining Syneron Medical Ltd position as of Q4 2015 after selling out during the quarter.
  • BlackRock Group sold 16,547 Syneron Medical Ltd shares in Q4 2015, an estimated $118K.
  • BlackRock Group first reported a position in Syneron Medical Ltd in Q2 2014 and held it in 6 quarters.
  • BlackRock Group's Syneron Medical Ltd position peaked at $205K in Q1 2015.
  • 57 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q4 2015.

Based on BlackRock Group's 13F filing for Q4 2015, filed 11 Feb 2016.